AMH and polycystic ovary syndrome: This finding further supports the inference that PCOS patients exhibit elevated serum AMH levels and the reduced biological potency of AMHR2 in the endometrium, leading to a weakened AMH-AMHR cascade signaling pathway and a consequent loss of the inhibitory effect on AEH.